Remimazolam combined with propofol for intraoperative wake-up testing in scoliosis correction surgery: a prospective, blind, randomized controlled trial
Frontiers in Pharmacology · 24.11.2025 · 16
DOI: 10.3389/fphar.2025.1685683 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.11.2025. Verfasst von Jing Luo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life science and Technology, Kunming University of Science and Technology, Kunming, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, Yunnan Provincial Science and Technology Department, Kunming University of Science and Technology.
Abstract (Originalsprache)
Purpose
Remimazolam is a fast-acting benzodiazepine used for anesthesia and sedation, notable for its quick onset and reversible effects. Its role in wake-up testing during spinal deformity surgery is uncertain. This study assessed the effectiveness and safety of combining remimazolam with propofol during wake-up tests in scoliosis correction surgery.
Methods
In this randomized trial, 54 scoliosis surgery patients were assigned to receive either propofol alone (Group P), propofol with dexmedetomidine (Group D), or propofol with remimazolam (Group R). Primary outcomes were wake-up time and quality; secondary outcomes included spinal monitoring, cerebral indices, hemodynamic stability, surgery duration, Visual Analog Scale and Behavioral Comfort Scale scores, satisfaction, and postoperative adverse events.
Results
Mean wake-up times varied significantly across groups: 10.58 ± 1.60 min (Group P), 16.14 ± 2.64 min (Group D), and 6.69 ± 3.85 min (Group R) ( p = 0.001). Post-hoc analysis revealed Group R had significantly shorter wake-up times than Group P (mean difference, 3.9 min; p = 0.0005) and Group D (mean difference, 9.4 min; p = 0.0001). Excellent wake-up quality was reported in 50% of Group P, 100% of Group D, and 94.4% of Group R ( p = 0.0002). Group R also had a shorter mean operative duration (256.3 ± 74.4 min) compared to Group P (264.4 ± 60.4 min) and Group D (310.9 ± 57.9 min) ( p = 0.03). Additionally, Group R showed significantly higher amnesia indices at multiple time points compared to Groups P and D ( p < 0.05). Hemodynamic assessments revealed that Group D had significantly lower heart rates at T2, T3, and T4 than Groups P and R ( p < 0.05). Group R also had a higher mean arterial pressure than Group P at T2 ( p < 0.05). Surgeon satisfaction scores were significantly higher in Group R than in Groups P and D ( p = 0.0001), and patient satisfaction scores in Group R were higher than in Group P ( p = 0.0001). No significant differences were observed in other secondary outcomes ( p > 0.05).
Conclusion
The remimazolam-propofol combo for intraoperative wake-up testing in scoliosis correction surgery shows superior efficacy with quicker wake-up times, better wakefulness quality, and higher satisfaction, without affecting spinal neurophysiological monitoring. This suggests it as a promising sedative option for spinal deformity surgeries. Clinical Trial Registration https://www.chictr.org.cn/bin/project/edit?pid=203900 as ChiCTR2300076802.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Life science and Technology, Kunming University of Science and Technology, Kunming, China.
- Department of Anesthesiology, The First People's Hospital of Yunnan Province &The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.
- Department of Anesthesiology, Simao District People's Hospital, Pu'er, China.
- Department of Orthopedics, The First People's Hospital of Yunnan Province &The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.
Förderung
- Innovative Research Group Project of the National Natural Science Foundation of China
- Yunnan Provincial Science and Technology Department
- Kunming University of Science and Technology
Zitieren
APA
Luo, J., Chen, D. L., Lv, Z. L., Zhong, H., Zhao, Y. H., Li, Y. J., Li, X. N., Chen, J. C., Shi, W. B., Bo, Y., Lin, R. Q., Yang, Y. Z., Lu, S., Li, W. S., & Jin, H. (2025). Remimazolam combined with propofol for intraoperative wake-up testing in scoliosis correction surgery: a prospective, blind, randomized controlled trial. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1685683
Vancouver
Luo J, Chen DL, Lv ZL, Zhong H, Zhao YH, Li YJ, et al. Remimazolam combined with propofol for intraoperative wake-up testing in scoliosis correction surgery: a prospective, blind, randomized controlled trial. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1685683
BibTeX
@article{Luo2025,
author = {Luo, Jing and Chen, Da-Lin and Lv, Zong-Long and Zhong, Hui and Zhao, Yong-Hui and Li, Yu-Jin and Li, Xin-Nan and Chen, Jing-Ce and Shi, Wen-Bao and Bo, Yun and Lin, Rong-Qian and Yang, You-Zhi and Lu, Sheng and Li, Wen-Sen and Jin, Hua},
title = {Remimazolam combined with propofol for intraoperative wake-up testing in scoliosis correction surgery: a prospective, blind, randomized controlled trial},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1685683}
}
EUVIMED